Iovance Biotherapeutics, Inc.
Shows how much buzz exceeds trading volume.
30-Day Trend
IOVA (Iovance Biotherapeutics, Inc.) is ranked #47 on the All Score, down from #43 (-4) across global retail investor sources tracked by FOMO Finder.
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Yahoo · Oct 16, 2026
Barclays Maintains Overweight on Iovance Biotherapeutics, Raises Price Target to $18
Benzinga · Oct 13, 2026
US market headlines from third-party sources. Updated daily.
Updated
